Outcomes After Brexucabtagene Autoleucel Administered as a Standard Therapy for Adults With Relapsed/Refractory B-Cell ALL
Brexucabtagene Autoleucel 作为复发/难治性 B 细胞急性淋巴细胞白血病成人患者的标准疗法后的疗效
期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.24.00321
Roloff, Gregory W; Aldoss, Ibrahim; Kopmar, Noam E; Lin, Chenyu; Dekker, Simone E; Gupta, Vishal K; O'Connor, Timothy E; Jeyakumar, Nikeshan; Muhsen, Ibrahim N; Valtis, Yannis; Ahmed, Naveed; Zhang, Amy; Miller, Katharine; Dykes, Kaitlyn C; Ahmed, Mohamed; Chen, Evan C; Mercadal, Santiago; Schwartz, Marc; Tracy, Sean I; Dholaria, Bhagirathbhai; Mukherjee, Akash; Battiwalla, Minoo; Logan, Aaron C; Ladha, Abdullah; Guzowski, Caitlin; Hoeg, Rasmus T; Hilal, Talal; Moore, Jozal; Connor, Matthew P; Hill, LaQuisa C; Tsai, Stephanie B; Sasine, Joshua P; Solh, Melhem M; Kota, Vamsi K; Koura, Divya; Veeraputhiran, Muthu; Leonard, Jessica T; Frey, Noelle V; Park, Jae H; Luskin, Marlise R; Bachanova, Veronika; Galal, Ahmed; Pullarkat, Vinod; Stock, Wendy; Cassaday, Ryan D; Shah, Bijal D; Faramand, Rawan; Muffly, Lori